Related Experiment Video
Updated: Aug 6, 2025

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
The role of mesenchymal stem cell-derived EVs in diabetic wound healing
Min Jiang1, Xupin Jiang1, Hongmei Li2
1Department of Plastic Surgery, State Key Laboratory of Trauma, Burns and Combined Injury, Southwest Hospital, The Third Military Medical University (Army Medical University), Chongqing, China.
Abstract:
Diabetic foot is one of the most common complications of diabetes, requiring repeated surgical interventions and leading to amputation. In the absence of effective drugs, new treatments need to be explored. Previous studies have found that stem cell transplantation can promote the healing of chronic diabetic wounds. However, safety issues have limited the clinical application of this technique. Recently, the performance of mesenchymal stem cells after transplantation has been increasingly attributed to their production of exocrine functional derivatives such as extracellular vesicles (EVs), cytokines, and cell-conditioned media. EVs contain a variety of cellular molecules, including RNA, DNA and proteins, which facilitate the exchange of information between cells. EVs have several advantages over parental stem cells, including a high safety profile, no immune response, fewer ethical concerns, and a reduced likelihood of embolism formation and carcinogenesis. In this paper, we summarize the current knowledge of mesenchymal stem cell-derived EVs in accelerating diabetic wound healing, as well as their potential clinic applications.
Insights
Mesenchymal stem cell-derived extracellular vesicles (EVs) show promise for accelerating diabetic wound healing. These EVs offer a safer alternative to stem cell transplantation for treating diabetic foot complications.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Diabetes Research
Background:
- Diabetic foot ulcers are a severe diabetes complication, often necessitating surgery and amputation.
- Current treatments for diabetic foot wounds are limited, driving the need for novel therapeutic strategies.
- Stem cell transplantation shows potential for wound healing but faces safety and clinical application challenges.
Purpose of the Study:
- To review the current understanding of mesenchymal stem cell-derived extracellular vesicles (EVs) in promoting diabetic wound healing.
- To explore the potential clinical applications of these EVs as a therapeutic approach.
Main Methods:
- Literature review of studies on mesenchymal stem cell (MSC) derivatives and diabetic wound healing.
- Analysis of the composition and function of extracellular vesicles (EVs).
- Evaluation of the safety profile and therapeutic advantages of EVs compared to parental stem cells.
Main Results:
- Mesenchymal stem cell (MSC) efficacy in wound healing is increasingly linked to their secreted EVs.
- EVs facilitate intercellular communication through their cargo of RNA, DNA, and proteins.
- EVs present a superior safety profile, avoiding immune responses, ethical concerns, and risks like embolism and carcinogenesis.
Conclusions:
- Mesenchymal stem cell-derived EVs represent a promising cell-free therapeutic strategy for accelerating diabetic wound healing.
- The inherent safety and efficacy of EVs warrant further investigation for clinical translation in managing diabetic foot complications.
Related Concept Videos
Mesenchymal Stem Cells
Clinical Applications of Epidermal Stem Cells
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Insulin Secretory Vesicles

